Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 SENP7 USP17L13	7.50e-09	137	151	11	GO:0019783
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	1.57e-08	114	151	10	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	3.54e-08	124	151	10	GO:0101005
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 SENP7 USP17L13	2.43e-07	192	151	11	GO:0008234
GeneOntologyMolecularFunction	RNA helicase activity	DDX59 DDX52 DHX30 DHX35 DDX11L8	3.13e-04	78	151	5	GO:0003724
GeneOntologyMolecularFunction	ATP-dependent activity, acting on RNA	DDX59 DDX52 DHX30 DHX35 DDX11L8	3.53e-04	80	151	5	GO:0008186
GeneOntologyMolecularFunction	fructose-6-phosphate binding	PFKFB1 PFKP	5.60e-04	5	151	2	GO:0070095
GeneOntologyMolecularFunction	ATP-dependent activity	KIF6 DDX59 DDX52 CHD7 DHX30 BPTF KCNJ8 ACSF3 DHX35 DNAH5 DDX11L8 TOP2A DYNC1H1	8.03e-04	614	151	13	GO:0140657
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 SENP7 USP17L13	7.38e-09	144	148	11	GO:0070646
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.34e-08	125	148	10	GO:0016579
GeneOntologyBiologicalProcess	neuronal-glial interaction involved in cerebral cortex radial glia guided migration	DAB1 LAMB1	5.11e-05	2	148	2	GO:0021812
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN3 NLGN4X	3.00e-04	4	149	2	GO:0098983
GeneOntologyCellularComponent	asymmetric, glutamatergic, excitatory synapse	OGT NLGN3 NLGN4X	6.44e-04	24	149	3	GO:0098985
GeneOntologyCellularComponent	collagen type IV trimer	COL4A5 COL4A6	7.43e-04	6	149	2	GO:0005587
GeneOntologyCellularComponent	chromatin	MYT1L OGT KDM5A HLCS CHD7 RFX7 JMJD1C NSD3 BPTF FOXP4 PRDM10 ARNT PBRM1 ARNT2 NFYC ANKRD17 ELF2 KLF17 USF1 MGA DDX11L8 EP300	8.11e-04	1480	149	22	GO:0000785
GeneOntologyCellularComponent	membrane coat	SYNRG SEC31A PICALM SEC24D AP2B1	9.78e-04	106	149	5	GO:0030117
GeneOntologyCellularComponent	coated membrane	SYNRG SEC31A PICALM SEC24D AP2B1	9.78e-04	106	149	5	GO:0048475
GeneOntologyCellularComponent	extrinsic component of presynaptic endocytic zone membrane	PICALM AP2B1	1.04e-03	7	149	2	GO:0098894
GeneOntologyCellularComponent	axon initial segment	KCNQ2 LRRC7 LGI1	1.13e-03	29	149	3	GO:0043194
GeneOntologyCellularComponent	vesicle coat	SYNRG SEC31A SEC24D AP2B1	1.34e-03	67	149	4	GO:0030120
GeneOntologyCellularComponent	aryl hydrocarbon receptor complex	ARNT ARNT2	1.37e-03	8	149	2	GO:0034751
GeneOntologyCellularComponent	basement membrane collagen trimer	COL4A5 COL4A6	1.37e-03	8	149	2	GO:0098651
GeneOntologyCellularComponent	network-forming collagen trimer	COL4A5 COL4A6	1.37e-03	8	149	2	GO:0098642
GeneOntologyCellularComponent	collagen network	COL4A5 COL4A6	1.37e-03	8	149	2	GO:0098645
GeneOntologyCellularComponent	inhibitory synapse	GPHN NLGN3 NLGN4X	1.38e-03	31	149	3	GO:0060077
HumanPheno	Vulvar neoplasm	COL4A5 COL4A6 DOCK8	1.48e-06	3	59	3	HP:0030416
MousePheno	abnormal posture	MYT1L GPHN SMAP1 KIF6 LAMB1 CHD7 LEPR NSD3 CAPRIN1 DYNC1H1	1.82e-05	243	108	10	MP:0001504
Domain	UCH	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	3.49e-09	71	143	9	PF00443
Domain	USP_2	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	3.49e-09	71	143	9	PS00973
Domain	USP_3	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	3.97e-09	72	143	9	PS50235
Domain	USP_dom	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	3.97e-09	72	143	9	IPR028889
Domain	Peptidase_C19_UCH	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	3.97e-09	72	143	9	IPR001394
Domain	USP_CS	USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	3.83e-08	66	143	8	IPR018200
Domain	USP_1	USP17L4 USP17L2 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	6.14e-08	70	143	8	PS00972
Domain	HABP4_PAI-RBP1	USP17L2 USP17L17 USP17L3 USP17L22 USP17L13	1.00e-07	16	143	5	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L2 USP17L17 USP17L3 USP17L22 USP17L13	1.00e-07	16	143	5	IPR006861
Domain	-	TLN1 TLN2	5.82e-05	2	143	2	1.20.1420.10
Domain	VBS	TLN1 TLN2	5.82e-05	2	143	2	PF08913
Domain	Vinculin-bd_dom	TLN1 TLN2	5.82e-05	2	143	2	IPR015009
Domain	Talin_cent	TLN1 TLN2	5.82e-05	2	143	2	IPR015224
Domain	Talin_middle	TLN1 TLN2	5.82e-05	2	143	2	PF09141
Domain	Talin-1	TLN1 TLN2	1.74e-04	3	143	2	IPR015710
Domain	ILWEQ_dom	TLN1 TLN2	3.46e-04	4	143	2	IPR002558
Domain	ILWEQ	TLN1 TLN2	3.46e-04	4	143	2	SM00307
Domain	FERM_f0	TLN1 TLN2	3.46e-04	4	143	2	PF16511
Domain	ILWEQ	TLN1 TLN2	3.46e-04	4	143	2	PD011820
Domain	-	TLN1 TLN2	3.46e-04	4	143	2	1.20.1410.10
Domain	I_LWEQ	TLN1 TLN2	3.46e-04	4	143	2	PF01608
Domain	I_LWEQ	TLN1 TLN2	3.46e-04	4	143	2	PS50945
Domain	FERM_f0	TLN1 TLN2	3.46e-04	4	143	2	IPR032425
Domain	Nlgn	NLGN3 NLGN4X	5.73e-04	5	143	2	IPR000460
Domain	C4	COL4A5 COL4A6	8.56e-04	6	143	2	SM00111
Domain	Collagen_VI_NC	COL4A5 COL4A6	8.56e-04	6	143	2	IPR001442
Domain	NC1_IV	COL4A5 COL4A6	8.56e-04	6	143	2	PS51403
Domain	-	COL4A5 COL4A6	8.56e-04	6	143	2	2.170.240.10
Domain	C4	COL4A5 COL4A6	8.56e-04	6	143	2	PF01413
Domain	Cadherin_C	CDH20 DSG4 CDH8	8.93e-04	25	143	3	PF01049
Domain	Cadherin_cytoplasmic-dom	CDH20 DSG4 CDH8	8.93e-04	25	143	3	IPR000233
Domain	Bromodomain_CS	BPTF PBRM1 EP300	1.00e-03	26	143	3	IPR018359
Domain	Vinculin/catenin	TLN1 TLN2	1.19e-03	7	143	2	IPR006077
Domain	U_BOX	UBE4B WDSUB1	1.19e-03	7	143	2	PS51698
Domain	Catenin_binding_dom	CDH20 DSG4 CDH8	1.39e-03	29	143	3	IPR027397
Domain	-	CDH20 DSG4 CDH8	1.39e-03	29	143	3	4.10.900.10
Domain	Helicase_C	DDX59 DDX52 CHD7 DHX30 DHX35	1.39e-03	107	143	5	PF00271
Domain	HELICc	DDX59 DDX52 CHD7 DHX30 DHX35	1.39e-03	107	143	5	SM00490
Domain	Helicase_C	DDX59 DDX52 CHD7 DHX30 DHX35	1.45e-03	108	143	5	IPR001650
Domain	Cadherin_CS	CDH20 DSG4 PCDH7 CDH8 CDHR4	1.51e-03	109	143	5	IPR020894
Domain	HELICASE_CTER	DDX59 DDX52 CHD7 DHX30 DHX35	1.51e-03	109	143	5	PS51194
Domain	HELICASE_ATP_BIND_1	DDX59 DDX52 CHD7 DHX30 DHX35	1.51e-03	109	143	5	PS51192
Domain	DEXDc	DDX59 DDX52 CHD7 DHX30 DHX35	1.51e-03	109	143	5	SM00487
Domain	Zinc_finger_PHD-type_CS	KDM5A MLLT10 NSD3 BPTF	1.55e-03	65	143	4	IPR019786
Domain	Helicase_ATP-bd	DDX59 DDX52 CHD7 DHX30 DHX35	1.58e-03	110	143	5	IPR014001
Domain	Ubox	UBE4B WDSUB1	1.58e-03	8	143	2	SM00504
Domain	DHC_N1	DNAH5 DYNC1H1	1.58e-03	8	143	2	PF08385
Domain	U-box	UBE4B WDSUB1	1.58e-03	8	143	2	PF04564
Domain	Nuc_translocat	ARNT ARNT2	1.58e-03	8	143	2	IPR001067
Domain	Dynein_heavy_dom-1	DNAH5 DYNC1H1	1.58e-03	8	143	2	IPR013594
Domain	CADHERIN_1	CDH20 DSG4 PCDH7 CDH8 CDHR4	1.78e-03	113	143	5	PS00232
Domain	Cadherin	CDH20 DSG4 PCDH7 CDH8 CDHR4	1.78e-03	113	143	5	PF00028
Domain	CADHERIN_2	CDH20 DSG4 PCDH7 CDH8 CDHR4	1.85e-03	114	143	5	PS50268
Domain	-	CDH20 DSG4 PCDH7 CDH8 CDHR4	1.85e-03	114	143	5	2.60.40.60
Domain	CA	CDH20 DSG4 PCDH7 CDH8 CDHR4	1.92e-03	115	143	5	SM00112
Domain	Cadherin-like	CDH20 DSG4 PCDH7 CDH8 CDHR4	1.99e-03	116	143	5	IPR015919
Domain	Cadherin	CDH20 DSG4 PCDH7 CDH8 CDHR4	2.15e-03	118	143	5	IPR002126
Domain	DEAD/DEAH_box_helicase_dom	DDX59 DDX52 DHX30 DHX35	2.38e-03	73	143	4	IPR011545
Domain	DEAD	DDX59 DDX52 DHX30 DHX35	2.38e-03	73	143	4	PF00270
Domain	DNA/RNA_helicase_DEAH_CS	CHD7 DHX30 DHX35	2.40e-03	35	143	3	IPR002464
Domain	Ubox_domain	UBE4B WDSUB1	2.52e-03	10	143	2	IPR003613
Domain	PHD	KDM5A MLLT10 NSD3 BPTF	2.63e-03	75	143	4	PF00628
Domain	BROMODOMAIN_1	BPTF PBRM1 EP300	2.82e-03	37	143	3	PS00633
Domain	Bromodomain	BPTF PBRM1 EP300	3.05e-03	38	143	3	PF00439
Domain	DEAH_ATP_HELICASE	CHD7 DHX30 DHX35	3.05e-03	38	143	3	PS00690
Domain	Znf_PHD-finger	KDM5A MLLT10 NSD3 BPTF	3.17e-03	79	143	4	IPR019787
Domain	BROMODOMAIN_2	BPTF PBRM1 EP300	3.79e-03	41	143	3	PS50014
Domain	Bromodomain	BPTF PBRM1 EP300	4.06e-03	42	143	3	IPR001487
Domain	BROMO	BPTF PBRM1 EP300	4.06e-03	42	143	3	SM00297
Domain	-	BPTF PBRM1 EP300	4.06e-03	42	143	3	1.20.920.10
Domain	Carboxylesterase_B_CS	NLGN3 NLGN4X	4.30e-03	13	143	2	IPR019819
Domain	PHD	KDM5A MLLT10 NSD3 BPTF	4.86e-03	89	143	4	SM00249
Domain	Dynein_heavy_chain_D4_dom	DNAH5 DYNC1H1	4.99e-03	14	143	2	IPR024317
Domain	Dynein_HC_stalk	DNAH5 DYNC1H1	4.99e-03	14	143	2	IPR024743
Domain	CARBOXYLESTERASE_B_2	NLGN3 NLGN4X	4.99e-03	14	143	2	PS00941
Domain	Dynein_heavy_dom-2	DNAH5 DYNC1H1	4.99e-03	14	143	2	IPR013602
Domain	DHC_N2	DNAH5 DYNC1H1	4.99e-03	14	143	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH5 DYNC1H1	4.99e-03	14	143	2	IPR011704
Domain	COesterase	NLGN3 NLGN4X	4.99e-03	14	143	2	PF00135
Domain	IRS	TLN1 TLN2	4.99e-03	14	143	2	PF02174
Domain	IRS_PTB	TLN1 TLN2	4.99e-03	14	143	2	IPR002404
Domain	MT	DNAH5 DYNC1H1	4.99e-03	14	143	2	PF12777
Domain	AAA_8	DNAH5 DYNC1H1	4.99e-03	14	143	2	PF12780
Domain	CarbesteraseB	NLGN3 NLGN4X	4.99e-03	14	143	2	IPR002018
Domain	AAA_5	DNAH5 DYNC1H1	4.99e-03	14	143	2	PF07728
Domain	Znf_PHD	KDM5A MLLT10 NSD3 BPTF	5.26e-03	91	143	4	IPR001965
Domain	DHC_fam	DNAH5 DYNC1H1	5.73e-03	15	143	2	IPR026983
Domain	Dynein_heavy	DNAH5 DYNC1H1	5.73e-03	15	143	2	PF03028
Domain	Dynein_heavy_dom	DNAH5 DYNC1H1	5.73e-03	15	143	2	IPR004273
Domain	ZF_PHD_2	KDM5A MLLT10 NSD3 BPTF	6.12e-03	95	143	4	PS50016
Domain	ZF_PHD_1	KDM5A MLLT10 NSD3 BPTF	6.35e-03	96	143	4	PS01359
Domain	Laminin_N	LAMB1 USH2A	6.51e-03	16	143	2	IPR008211
Domain	LamNT	LAMB1 USH2A	6.51e-03	16	143	2	SM00136
Domain	LAMININ_NTER	LAMB1 USH2A	6.51e-03	16	143	2	PS51117
Domain	Laminin_N	LAMB1 USH2A	6.51e-03	16	143	2	PF00055
Domain	SET_dom	NSD3 PRDM1 PRDM10	6.62e-03	50	143	3	IPR001214
Domain	SET	NSD3 PRDM1 PRDM10	6.62e-03	50	143	3	PS50280
Domain	Gal_mutarotase_SF_dom	SI LGI1	7.34e-03	17	143	2	IPR011013
Domain	DUF1605	DHX30 DHX35	7.34e-03	17	143	2	IPR011709
Domain	OB_NTP_bind	DHX30 DHX35	7.34e-03	17	143	2	PF07717
Pathway	REACTOME_RAS_PROCESSING	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	1.84e-12	45	113	10	MM15671
Pathway	REACTOME_DEUBIQUITINATION	USP17L4 OGT USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 EP300 USP17L8 USP17L13	1.24e-06	262	113	12	MM15286
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	3.05e-06	191	113	10	MM15289
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 TLN1 USP17L6P USP17L3 LRRC7 USP17L22 USP17L8 USP17L13	9.09e-06	318	113	12	MM15278
Pathway	REACTOME_DEUBIQUITINATION	USP17L4 OGT USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 EP300 USP17L8 USP17L13	2.77e-05	299	113	11	M27574
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	7.07e-05	221	113	9	M27578
Pathway	REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAMLD1 EP300 NOTCH2	1.05e-04	12	113	3	M27159
Pathway	REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA	DUXB YAP1 EP300	3.14e-04	17	113	3	M48025
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	5.95e-19	21	151	10	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	5.95e-19	21	151	10	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	5.95e-19	21	151	10	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	5.95e-19	21	151	10	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	5.95e-19	21	151	10	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	5.95e-19	21	151	10	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	1.09e-18	22	151	10	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	3.27e-18	24	151	10	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	5.44e-18	25	151	10	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	8.80e-18	26	151	10	35816173
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	3.28e-17	29	151	10	32527007
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	1.49e-16	33	151	10	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.11e-16	34	151	10	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.94e-16	35	151	10	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.94e-16	35	151	10	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	4.06e-16	36	151	10	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	5.54e-16	37	151	10	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	1.56e-14	50	151	10	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L8	1.25e-12	10	151	6	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L8	5.48e-12	12	151	6	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L8	1.77e-11	14	151	6	11793228
Pubmed	Human transcription factor protein interaction networks.	OGT KDM5A SOBP DDX52 CHD7 MLLT10 PFKP RFX7 CIT JMJD1C DHX30 PRDM1 BPTF FOXP4 ARNT PBRM1 YAP1 NFYC ANKRD17 ELF2 SCAF11 MGA PCDH7 CAPRIN1 PRRC2A EP300 DYNC1H1 SYMPK	2.10e-11	1429	151	28	35140242
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L8	1.57e-10	19	151	6	28067227
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SYNRG UBE4B KDM5A CAST CHD7 PFKP RFX7 PNISR BPTF YAP1 ANKRD17 TLN2 ELF2 SCAF11 DNMBP PCDH7 PRRC2A TOP2A NOTCH2 SYMPK	1.90e-10	774	151	20	15302935
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPHN OGT KDM5A NHSL2 CHD7 SEC31A CIT PICALM NLGN3 PBRM1 AP2B1 KIAA1217 PPP1R3F ANKRD17 TLN2 LRRC7 MGA CAPRIN1 PRRC2A DYNC1H1 WNK3 LGI1	2.24e-10	963	151	22	28671696
Pubmed	Interaction network of human early embryonic transcription factors.	OGT KDM5A SOBP CHD7 RFX7 DUXB BPTF FOXP4 ARNT PBRM1 ELF2 MGA EP300 TOP2A	4.99e-10	351	151	14	38297188
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GPHN SYNRG OGT CAST JMJD1C NSD3 BPTF YAP1 TLN1 MGA PRRC2A EP300 TOP2A DYNC1H1 SYMPK	1.96e-08	549	151	15	38280479
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	OGT LAMB1 MLLT10 IDH3G JMJD1C BPTF PBRM1 ANKRD17 DYNC1H1 SYMPK	2.25e-08	203	151	10	22083510
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	OGT KDM5A DDX52 UBQLN4 CHD7 NCLN RFX7 PNISR JMJD1C NSD3 BPTF ARNT PBRM1 YAP1 ELF2 SCAF11 USF1 MGA EP300 TOP2A SYMPK C1orf174	4.75e-08	1294	151	22	30804502
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	COL4A5 OGT UBE4B SOBP CAST DAB1 PFKFB1 INTS8 ADCY3 JMJD1C HIPK3 BPTF NLGN3 FOXP4 MBNL2 KIAA1217 ACSF3 ANKRD17 SCAF11 LRRC7 EP300 VPS13B NOTCH2	1.28e-07	1489	151	23	28611215
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYT1L OGT UBE4B KDM5A UBQLN4 HLCS LAMB1 SEC31A PNISR INTS8 CIT DHX30 AP2B1 KCNQ2 TLN2 DHX35 CAPRIN1 PRRC2A EP300 DYNC1H1 LGI1	1.91e-07	1285	151	21	35914814
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	GPHN OGT KDM5A DDX52 JMJD1C BPTF FOXP4 PRDM10 ARNT NFYC ANKRD17 MGA EP300 TOP2A DYNC1H1 NOTCH2 SYMPK	2.17e-07	857	151	17	25609649
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L4 USP17L2 USP17L1 NHSL2 USP17L10 OPHN1 NLGN3 USP17L17 USP17L6P USP17L3 USP17L22 WNK3 USP17L8 LGI1 USP17L13	2.78e-07	674	151	15	37196079
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	OGT DOCK8 CHD7 CIT JMJD1C BPTF ARNT CELF2 AP2B1 TLN1 MIF ELF2 USF1 CAPRIN1 PRRC2A EP300 TOP2A DYNC1H1 IPO11	3.49e-07	1103	151	19	34189442
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	GPHN UBE4B CIT NLGN3 NLGN4X AP2B1 TLN2 LRRC7 PCDH7 DYNC1H1	4.65e-07	281	151	10	28706196
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	OGT KDM5A CHD7 JMJD1C ZBTB24 NSD3 BPTF PBRM1 ELF2 SCAF11 USF1 MGA TOP2A SENP7	4.72e-07	608	151	14	36089195
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	SMAP1 SYNRG MAMLD1 PICALM JMJD1C ARNT TLN1 ELF2 MGA CAPRIN1 TOP2A SYMPK	6.12e-07	444	151	12	34795231
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	CHD7 SEC31A JMJD1C HIPK3 BPTF MBNL2 KIAA1217 TLN2 SCAF11 PRRC2A NOTCH2 IPO11 SYMPK	6.93e-07	536	151	13	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	CHD7 SEC31A JMJD1C HIPK3 BPTF MBNL2 KIAA1217 TLN2 SCAF11 PRRC2A NOTCH2 IPO11 SYMPK	7.23e-07	538	151	13	10512203
Pubmed	Quantification of integrin receptor agonism by fluorescence lifetime imaging.	ITGA4 TLN1 TLN2	7.97e-07	5	151	3	18216331
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPHN SMAP1 OGT DOCK8 SCAMP1 PFKP CIT OMG OPHN1 DHX30 NLGN3 AP2B1 KIAA1217 TLN1 KCNQ2 TLN2 LRRC7 CAPRIN1 PRRC2A DYNC1H1 LGI1	1.09e-06	1431	151	21	37142655
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	DDX52 CHD7 PFKP DHX30 BPTF PBRM1 AP2B1 TLN1 ANKRD17 SCAF11 CAPRIN1 PRRC2A DYNC1H1 SYMPK	1.10e-06	653	151	14	22586326
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	OGT DDX52 UBQLN4 CHD7 NSD3 PBRM1 AP2B1 MIF SCAF11 PRRC2A TOP2A	1.34e-06	394	151	11	27248496
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L8	1.50e-06	81	151	6	12838346
Pubmed	The Wilms tumor gene, Wt1, maintains testicular cord integrity by regulating the expression of Col4a1 and Col4a2.	COL4A5 COL4A6 LAMB1 ITGA4	1.93e-06	21	151	4	23325811
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	MYT1L KDM5A MLLT10 ZBTB24 PRDM1 BPTF ARNT PBRM1 MBNL2 ARNT2 NFYC ELF2 KLF17 USF1 MGA	2.64e-06	808	151	15	20412781
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	MLLT10 NSD3 DHX30 BPTF FOXP4 AP2B1 TLN1 SCAF11 PRRC2A DYNC1H1	5.46e-06	370	151	10	22922362
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	CHD7 NSD3 DHX30 PBRM1 ELF2 MGA	8.49e-06	109	151	6	33554859
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	OGT DDX52 LAMB1 PFKP RFX7 CIT DHX30 ARNT AP2B1 YAP1 TLN1 ANKRD17 DHX35 MGA CAPRIN1 PRRC2A TOP2A DYNC1H1	8.53e-06	1247	151	18	27684187
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	OGT UBQLN4 JMJD1C BPTF FOXP4 PBRM1 MGA	8.96e-06	167	151	7	20362541
Pubmed	A human MAP kinase interactome.	INTS6L LAMB1 SEC31A PNISR NSD3 HIPK3 AP2B1 NFYC ANKRD17 MGA EP300	9.84e-06	486	151	11	20936779
Pubmed	Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo.	PFKP AP2B1 DYNC1H1 LGI1	1.27e-05	33	151	4	26025364
Pubmed	Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development.	COL4A5 COL4A6 LAMB1	1.29e-05	11	151	3	14998921
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GPHN SYNRG CAST HLCS PFKP PICALM DHX30 AP2B1 KIAA1217 TLN1 MIF ANKRD17 ELF2 PRRC2A TOP2A	1.48e-05	934	151	15	33916271
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	OGT PNISR DHX30 BPTF ELF2 SCAF11 TOP2A SYMPK	1.50e-05	251	151	8	31076518
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	CAST PFKP BPTF PBRM1 TLN1 SCAF11 TOP2A DYNC1H1 SYMPK	1.59e-05	332	151	9	32786267
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	SYNRG KDM5A CAST SEC31A CELF2 MBNL2 TLN1 ANKRD17 DHX35 DNMBP MGA CAPRIN1 PRRC2A	1.79e-05	724	151	13	36232890
Pubmed	A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.	OGT DDX52 PFKP MGA DYNC1H1 SYMPK	1.86e-05	125	151	6	21654808
Pubmed	Divergent expression patterns for hypoxia-inducible factor-1beta and aryl hydrocarbon receptor nuclear transporter-2 in developing kidney.	ARNT ARNT2	1.87e-05	2	151	2	15466261
Pubmed	Association Analysis of Noncoding Variants in Neuroligins 3 and 4X Genes with Autism Spectrum Disorder in an Italian Cohort.	NLGN3 NLGN4X	1.87e-05	2	151	2	27782075
Pubmed	Not all neuroligin 3 and 4X missense variants lead to significant functional inactivation.	NLGN3 NLGN4X	1.87e-05	2	151	2	28948087
Pubmed	Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism.	NLGN3 NLGN4X	1.87e-05	2	151	2	16648374
Pubmed	A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population.	NLGN3 NLGN4X	1.87e-05	2	151	2	19645625
Pubmed	CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12.	MLLT10 PICALM	1.87e-05	2	151	2	22064352
Pubmed	Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors.	COL4A5 COL4A6	1.87e-05	2	151	2	8356449
Pubmed	Mutation screening of X-chromosomal neuroligin genes: no mutations in 196 autism probands.	NLGN3 NLGN4X	1.87e-05	2	151	2	15274046
Pubmed	Depletion of homeodomain-interacting protein kinase 3 impairs insulin secretion and glucose tolerance in mice.	LEPR HIPK3	1.87e-05	2	151	2	22983607
Pubmed	Differential expression of mouse alpha5(IV) and alpha6(IV) collagen genes in epithelial basement membranes.	COL4A5 COL4A6	1.87e-05	2	151	2	10965041
Pubmed	YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.	MAMLD1 YAP1	1.87e-05	2	151	2	31477715
Pubmed	Immunohistochemical localization of type IV collagen alpha chains in the basement membrane of the pancreatic duct in human normal pancreas and pancreatic diseases.	COL4A5 COL4A6	1.87e-05	2	151	2	15211113
Pubmed	The clathrin-binding domain of CALM-AF10 alters the phenotype of myeloid neoplasms in mice.	MLLT10 PICALM	1.87e-05	2	151	2	21706055
Pubmed	No evidence for involvement of genetic variants in the X-linked neuroligin genes NLGN3 and NLGN4X in probands with autism spectrum disorder on high functioning level.	NLGN3 NLGN4X	1.87e-05	2	151	2	18189281
Pubmed	Clonal overgrowth of esophageal smooth muscle cells in diffuse leiomyomatosis-Alport syndrome caused by partial deletion in COL4A5 and COL4A6 genes.	COL4A5 COL4A6	1.87e-05	2	151	2	20951201
Pubmed	Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides.	MLLT10 PICALM	1.87e-05	2	151	2	9737689
Pubmed	Disorder-associated mutations lead to functional inactivation of neuroligins.	NLGN3 NLGN4X	1.87e-05	2	151	2	15150161
Pubmed	Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients.	NLGN3 NLGN4X	1.87e-05	2	151	2	15622415
Pubmed	Bifunctional promoter of type IV collagen COL4A5 and COL4A6 genes regulates the expression of alpha5 and alpha6 chains in a distinct cell-specific fashion.	COL4A5 COL4A6	1.87e-05	2	151	2	15598179
Pubmed	Unique and overlapping transcriptional roles of arylhydrocarbon receptor nuclear translocator (Arnt) and Arnt2 in xenobiotic and hypoxic responses.	ARNT ARNT2	1.87e-05	2	151	2	17023418
Pubmed	Single-Cell Transcriptome Profiling of Pancreatic Islets From Early Diabetic Mice Identifies Anxa10 for Ca2+ Allostasis Toward β-Cell Failure.	LEPR ANXA10	1.87e-05	2	151	2	37871012
Pubmed	Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.	TLN1 TLN2	1.87e-05	2	151	2	26822056
Pubmed	Extracellular rigidity sensing by talin isoform-specific mechanical linkages.	TLN1 TLN2	1.87e-05	2	151	2	26523364
Pubmed	Endothelial Aryl Hydrocarbon Receptor Nuclear Translocator Mediates the Angiogenic Response to Peripheral Ischemia in Mice With Type 2 Diabetes Mellitus.	LEPR ARNT	1.87e-05	2	151	2	34179020
Pubmed	Nuclear export signal within CALM is necessary for CALM-AF10-induced leukemia.	MLLT10 PICALM	1.87e-05	2	151	2	24397609
Pubmed	The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.	MLLT10 PICALM	1.87e-05	2	151	2	18037964
Pubmed	Analysis of the genes encoding neuroligins NLGN3 and NLGN4 in Bulgarian patients with autism.	NLGN3 NLGN4X	1.87e-05	2	151	2	23431752
Pubmed	Absence of coding mutations in the X-linked genes neuroligin 3 and neuroligin 4 in individuals with autism from the IMGSAC collection.	NLGN3 NLGN4X	1.87e-05	2	151	2	16508939
Pubmed	Alport syndrome and leiomyomatosis: the first deletion extending beyond COL4A6 intron 2.	COL4A5 COL4A6	1.87e-05	2	151	2	21380622
Pubmed	NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population.	NLGN3 NLGN4X	1.87e-05	2	151	2	15389766
Pubmed	Tissue- and developmental stage-specific activation of alpha 5 and alpha 6(IV) collagen expression in the upper gastrointestinal tract of transgenic mice.	COL4A5 COL4A6	1.87e-05	2	151	2	14592452
Interaction	H2BC21 interactions	INTS6L DDX52 UBQLN4 LAMB1 CHD7 MLLT10 JMJD1C NSD3 BPTF PBRM1 AP2B1 TLN1 SCAF11 DNAH5 PRRC2A EP300 TOP2A DYNC1H1 SENP7	4.52e-07	696	142	19	int:H2BC21
Interaction	TEAD1 interactions	CHD7 CIT BPTF ARNT PBRM1 YAP1 ARNT2 ELF2 MGA EP300	4.91e-07	176	142	10	int:TEAD1
Interaction	POU5F1 interactions	OGT LAMB1 CHD7 MLLT10 IDH3G JMJD1C BPTF FOXP4 PBRM1 NFYC ANKRD17 SCAF11 MGA TOP2A DYNC1H1 SYMPK	3.75e-06	584	142	16	int:POU5F1
Interaction	KLF3 interactions	KDM5A SOBP RFX7 JMJD1C BPTF FOXP4 PBRM1 ELF2 MGA EP300	5.09e-06	228	142	10	int:KLF3
Interaction	H3C1 interactions	KDM5A DDX52 ACTR10 CAST CHD7 ITGA4 JMJD1C ZBTB24 NSD3 BPTF PBRM1 AP2B1 ELF2 DHX35 USF1 MGA EP300 TOP2A DYNC1H1 C1orf174	5.29e-06	901	142	20	int:H3C1
Interaction	H2AC4 interactions	DDX52 TRIM41 UBQLN4 ITGA4 CIT PRDM10 PBRM1 AP2B1 YAP1 SCAF11 DNAH5 PRRC2A EP300 TOP2A	1.41e-05	506	142	14	int:H2AC4
Interaction	RBPJL interactions	YAP1 ARNT2 PCDH7 EP300	1.89e-05	23	142	4	int:RBPJL
Interaction	TWIST1 interactions	USP17L2 CHD7 NSD3 DHX30 PBRM1 ELF2 MGA EP300	2.80e-05	170	142	8	int:TWIST1
Interaction	TGFB1I1 interactions	UBQLN4 ITGA4 HIPK3 YAP1 EP300	3.54e-05	53	142	5	int:TGFB1I1
Interaction	KLF15 interactions	ZBTB24 DHX30 FOXP4 PBRM1 YAP1 NFYC MGA CAPRIN1 PRRC2A EP300	4.07e-05	290	142	10	int:KLF15
Interaction	WWTR1 interactions	GPHN SYNRG OGT JMJD1C BPTF ARNT YAP1 TLN1 ARNT2 PRRC2A EP300 TOP2A	4.56e-05	422	142	12	int:WWTR1
Interaction	H3C3 interactions	KDM5A CHD7 ITGA4 JMJD1C ZBTB24 NSD3 BPTF PBRM1 ELF2 SCAF11 MGA TOP2A SENP7	4.94e-05	495	142	13	int:H3C3
Interaction	SP7 interactions	CHD7 PFKP DHX30 FOXP4 ARNT PBRM1 ELF2 MGA PCDH7 EP300	6.05e-05	304	142	10	int:SP7
Interaction	HNF1B interactions	CHD7 MLLT10 PRDM1 BPTF PBRM1 YAP1 MGA EP300	6.16e-05	190	142	8	int:HNF1B
Interaction	DUXA interactions	CHD7 BPTF TOP2A	7.19e-05	12	142	3	int:DUXA
Interaction	SIRT7 interactions	USP17L2 DDX52 CHD7 PFKP DHX30 BPTF PBRM1 AP2B1 TLN1 ANKRD17 SCAF11 CAPRIN1 PRRC2A TOP2A DYNC1H1 SYMPK	7.24e-05	744	142	16	int:SIRT7
Interaction	KLF5 interactions	OGT MLLT10 FOXP4 PBRM1 YAP1 MGA PRRC2A EP300	7.39e-05	195	142	8	int:KLF5
Interaction	SUMO2 interactions	SOBP CAST TDG PFKP BPTF PBRM1 TLN1 MIF SCAF11 EP300 TOP2A DYNC1H1 SENP7 SYMPK	7.63e-05	591	142	14	int:SUMO2
Interaction	BPTF interactions	CIT DUXB NSD3 BPTF PBRM1 YAP1 ELF2 USF1	7.94e-05	197	142	8	int:BPTF
Interaction	CRX interactions	SMAP1 CHD7 PICALM FOXP4 ARNT PBRM1 NFYC MGA EP300	8.11e-05	254	142	9	int:CRX
Interaction	FEV interactions	CHD7 MLLT10 FOXP4 ARNT PBRM1 YAP1 MGA EP300	9.78e-05	203	142	8	int:FEV
Interaction	POGZ interactions	DAB1 CIT PICALM ZBTB24 DUXB YAP1 NFYC ELF2 MGA	1.12e-04	265	142	9	int:POGZ
Interaction	SEC24C interactions	SEC31A ITGA4 CIT PICALM SEC24D AP2B1 EP300 NOTCH2	1.12e-04	207	142	8	int:SEC24C
Interaction	OXSR1 interactions	OGT PFKP CIT EP300 DYNC1H1 WNK3 LGI1	1.16e-04	155	142	7	int:OXSR1
Interaction	AGAP2 interactions	GPHN UBE4B NLGN3 AP2B1 TLN2 LRRC7 PCDH7 DYNC1H1	1.24e-04	210	142	8	int:AGAP2
Interaction	SOX6 interactions	SOBP CHD7 DHX30 FOXP4 ARNT CAPRIN1 PRRC2A	1.26e-04	157	142	7	int:SOX6
Interaction	HDAC2 interactions	OGT USP17L2 KDM5A UBQLN4 PFKP CIT JMJD1C PRDM1 BPTF AP2B1 YAP1 ANKRD17 CAPRIN1 EP300 TOP2A DYNC1H1 SYMPK	1.28e-04	865	142	17	int:HDAC2
Interaction	CIART interactions	OGT DAB1 NFYC	1.46e-04	15	142	3	int:CIART
Interaction	DYRK1A interactions	MYT1L OGT LAMB1 PFKP RFX7 PNISR CIT PICALM AP2B1 KIAA1217 PPP1R3F EP300 NOTCH2	1.47e-04	552	142	13	int:DYRK1A
Interaction	HNRNPD interactions	OGT SEC31A ITGA4 CIT PICALM DHX30 YAP1 TLN1 TLN2 PCDH7 EP300 TOP2A DYNC1H1 IPO11	1.70e-04	638	142	14	int:HNRNPD
Interaction	PA2G4 interactions	OGT DOCK8 LAMB1 ITGA4 CIT YAP1 PCDH7 CAPRIN1 EP300	1.88e-04	284	142	9	int:PA2G4
Interaction	RBBP5 interactions	OGT CHD7 CIT ELF2 USF1 MGA EP300 TOP2A SYMPK	2.04e-04	287	142	9	int:RBBP5
Interaction	SETD1A interactions	OGT PNISR YAP1 NFYC ELF2 USF1 EP300	2.06e-04	170	142	7	int:SETD1A
Interaction	PRRC2C interactions	UBQLN4 ITGA4 CIT YAP1 TLN1 ANKRD17 CAPRIN1 PRRC2A TOP2A	2.20e-04	290	142	9	int:PRRC2C
Interaction	H2BC8 interactions	DDX59 TRIM41 CHD7 ITGA4 ZBTB24 NSD3 BPTF PBRM1 ELF2 SCAF11 MGA TOP2A C1orf174	2.23e-04	576	142	13	int:H2BC8
Interaction	FOXP3 interactions	MLLT10 NSD3 DHX30 BPTF FOXP4 AP2B1 TLN1 SCAF11 PRRC2A EP300 DYNC1H1	2.49e-04	432	142	11	int:FOXP3
Interaction	NCOR1 interactions	SEC31A PRDM1 BPTF ARNT YAP1 MIF ARNT2 MGA EP300 SENP7	2.57e-04	363	142	10	int:NCOR1
Interaction	DUXB interactions	CHD7 DUXB BPTF	2.59e-04	18	142	3	int:DUXB
Interaction	MTA2 interactions	GPHN CHD7 PFKP CIT DHX30 BPTF YAP1 CAPRIN1 EP300 TOP2A SYMPK	2.65e-04	435	142	11	int:MTA2
Interaction	H3-3A interactions	OGT KDM5A CHD7 ITGA4 JMJD1C NSD3 BPTF PBRM1 ELF2 SCAF11 USF1 MGA EP300 TOP2A SENP7	2.66e-04	749	142	15	int:H3-3A
Interaction	ELF1 interactions	CIT BPTF PBRM1 NFYC ELF2 MGA	2.71e-04	126	142	6	int:ELF1
Interaction	SOX7 interactions	CHD7 JMJD1C FOXP4 PBRM1 EP300	2.86e-04	82	142	5	int:SOX7
Cytoband	4p16.1	USP17L10 USP17L17 USP17L6P USP17L22 USP17L13	6.67e-06	79	151	5	4p16.1
Cytoband	8p23.1	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.64e-04	154	151	5	8p23.1
Cytoband	6q21	SOBP ZBTB24 PRDM1 TUBE1	2.95e-04	96	151	4	6q21
Cytoband	Ensembl 112 genes in cytogenetic band chr6q21	SOBP ZBTB24 PRDM1 TUBE1	7.09e-04	121	151	4	chr6q21
Cytoband	13q32	CLYBL GPC5	8.19e-04	13	151	2	13q32
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L10 USP17L17 USP17L6P USP17L22 USP17L13	8.73e-04	222	151	5	chr4p16
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.10e-03	234	151	5	chr8p23
Coexpression	MADAN_DPPA4_TARGETS	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	5.56e-11	86	147	10	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	7.85e-10	112	147	10	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.51e-08	160	147	10	MM1155
Coexpression	BRUINS_UVC_RESPONSE_LATE	ATPSCKMT COL4A5 TCTN3 USP17L4 DDX59 USP17L2 USP17L1 CAST USP17L10 MLLT10 USP17L17 MBNL2 TLN1 UGT2A1 USP17L6P USP17L3 PPP1R3F TLN2 USP17L22 DNMBP USP17L8 USP17L13	9.49e-07	1198	147	22	MM1062
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	UBE4B DOCK8 CHD7 RFX7 BPTF PRDM10 TLN1 EP300	8.37e-06	180	147	8	M8239
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	INTS6L SYNRG OGT KDM5A DOCK8 HLA-DPB1 ZFAND5 ITGA4 RFX7 PNISR PICALM JMJD1C PRDM1 BPTF CELF2 C19orf12 TLN1 SCAF11 EP300 DYNC1H1 VPS13B NOTCH2 SENP7	9.74e-06	1492	147	23	M40023
Coexpression	GSE3039_CD4_TCELL_VS_NKT_CELL_UP	CDKL4 MLLT10 ADCY3 HIPK3 CELF2 HEBP1 NOTCH2 SENP7	1.80e-05	200	147	8	M6426
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	OGT KDM5A SCAMP1 MAMLD1 TDG PNISR PICALM BPTF SEC24D YAP1 ARNT2 NFYC ANKRD17 DNMBP TOP2A VPS13B	2.63e-05	856	147	16	M4500
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	SYNRG USP17L4 OGT USP17L2 USP17L1 KDM5A USP17L10 ZFAND5 PICALM PBRM1 USP17L17 USP17L6P USP17L3 USF1 USP17L22 PRRC2A USP17L8 USP17L13	3.32e-05	1072	147	18	MM1031
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	OGT KDM5A MAMLD1 PNISR PICALM BPTF YAP1 NFYC ANKRD17 DNMBP TOP2A	6.75e-05	466	147	11	M13522
Coexpression	NABA_BASEMENT_MEMBRANES	COL4A5 COL4A6 LAMB1 USH2A	7.42e-05	40	147	4	M5887
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	COL4A5 OGT KDM5A DOCK8 DAB1 LAMB1 INTS8 HIPK3 BPTF KIAA1217 ARNT2 ELF2 DNMBP MGA CAPRIN1 VPS13B	2.32e-09	379	134	16	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	INTS6L COL4A5 OGT KDM5A DOCK8 DAB1 LAMB1 CHD7 PFKP PNISR INTS8 HIPK3 BPTF KIAA1217 ARNT2 ELF2 DNMBP MGA TUBE1 CAPRIN1 VPS13B	2.73e-08	795	134	21	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	INTS6L COL4A5 COL4A6 NHSL2 ITGA4 PNISR CIT JMJD1C NSD3 MBNL2 HPGD KIAA1217 KCNJ8 SCAF11 ARHGAP20 MGA TUBE1 TOP2A SENP7	6.66e-07	799	134	19	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	COL4A5 NHSL2 PNISR CIT JMJD1C NSD3 PBRM1 KIAA1217 ARHGAP20 TUBE1 SENP7	1.52e-06	277	134	11	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	INTS6L COL4A5 COL4A6 NHSL2 ITGA4 PNISR CIT JMJD1C NSD3 KIAA1217 KCNJ8 TLN1 SCAF11 ARHGAP20 MGA TUBE1 TOP2A	1.02e-05	790	134	17	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	OGT KDM5A LAMB1 INTS8 HIPK3 ARNT2 DNMBP TUBE1 PCDH7 CAPRIN1 IPO11	1.05e-05	339	134	11	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000	COL4A5 OGT KDM5A DOCK8 LAMB1 PNISR KIAA1217 ELF2 TUBE1 PCDH7 CAPRIN1	2.66e-05	375	134	11	gudmap_developingKidney_e15.5_cortic collect duct_1000_k4
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500	INTS6L NHSL2 LAMB1 ZFAND5 MBNL2 MGA PRRC2A	3.65e-05	144	134	7	gudmap_developingGonad_e11.5_testes_k3_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	NHSL2 PNISR NSD3 PRDM1 PBRM1 KIAA1217 ARHGAP20 TUBE1 SENP7	4.03e-05	259	134	9	gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000	COL4A5 OGT KDM5A DOCK8 LAMB1 INTS8 HIPK3 DNMBP VPS13B	4.28e-05	261	134	9	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	INTS6L COL4A5 NHSL2 ITGA4 PNISR NSD3 KCNJ8 SCAF11 ARHGAP20 MGA TUBE1	5.23e-05	404	134	11	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	INTS6L COL4A5 NHSL2 ITGA4 PNISR NSD3 KIAA1217 KCNJ8 ARHGAP20 MGA TUBE1	5.47e-05	406	134	11	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	INTS6L COL4A5 NHSL2 ITGA4 PNISR KIAA1217 SCAF11 ARHGAP20 MGA TUBE1 SENP7	6.38e-05	413	134	11	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500	INTS6L NHSL2 ITGA4 SCAF11 MGA	9.26e-05	72	134	5	gudmap_developingGonad_e18.5_epididymis_500_k5
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500	INTS6L NHSL2 UBQLN4 LAMB1 ZFAND5 FOXP4 MBNL2 MGA CAPRIN1 PRRC2A SYMPK	1.05e-04	437	134	11	gudmap_developingGonad_e11.5_testes_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	GPHN SMAP1 TCTN3 DDX59 ACER3 SOBP TRIM41 CHD7 CIT PICALM OPHN1 DHX30 PSTK NFYC SCAF11	1.23e-04	780	134	15	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000	INTS6L SMAP1 OGT NHSL2 UBQLN4 ZFAND5 SEC31A FOXP4 MBNL2 MGA CAPRIN1 PRRC2A	1.24e-04	524	134	12	gudmap_developingGonad_e12.5_testes_k1_1000
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05	OGT TIGD1 CAST ZFAND5 PFKP RFX7 PNISR NLGN3 MBNL2 HEBP1 KIAA1217 ARNT2 PPP1R3F CDH8 TOP2A NOTCH2 LGI1	1.27e-04	967	134	17	PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000	OGT KDM5A DAB1 CDKL4 LAMB1 INTS8 DHX30 HIPK3 ARNT2 DNMBP TUBE1 PCDH7 CAPRIN1 IPO11 C1orf174	1.65e-04	801	134	15	gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	INTS6L COL4A5 NHSL2 LAMB1 ITGA4 PNISR JMJD1C NSD3 KIAA1217 KCNJ8 SCAF11 ARHGAP20 MGA TUBE1 SENP7	1.65e-04	801	134	15	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	INTS6L COL4A5 NHSL2 PNISR CIT JMJD1C NSD3 PBRM1 KIAA1217 ANKRD17 SCAF11 ARHGAP20 MGA TUBE1 SENP7	1.72e-04	804	134	15	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000	INTS6L SMAP1 OGT NHSL2 UBQLN4 LAMB1 ZFAND5 SEC31A ITGA4 FOXP4 MBNL2 MGA CAPRIN1 PRRC2A TOP2A	2.10e-04	819	134	15	gudmap_developingGonad_e12.5_testes_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	NHSL2 PNISR CIT JMJD1C NSD3 PBRM1 ARHGAP20 TUBE1 SENP7	2.16e-04	323	134	9	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500	INTS6L NHSL2 ITGA4 SCAF11 MGA	2.80e-04	91	134	5	gudmap_developingGonad_e14.5_ epididymis_500_k5
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500	DOCK8 LAMB1 PFKP ARNT2 ELF2 TUBE1 CAPRIN1	2.92e-04	201	134	7	gudmap_developingKidney_e15.5_500_k3
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05	COL4A5 COL4A6 OGT DOCK8 TRIM41 CAST HLCS LAMB1 PNISR LEPR FOXP4 MBNL2 KIAA1217 C19orf12 PPP1R3F WDSUB1 PCDH7 CDH8 NOTCH2 SENP7 LGI1	3.41e-04	1466	134	21	PCBC_ratio_ECTO_vs_SC_cfr-2X-p05
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000	INTS6L COL4A5 OGT KDM5A DOCK8 DAB1 LAMB1 PNISR HEBP1 KIAA1217 ELF2 TUBE1 PCDH7 CAPRIN1	3.90e-04	774	134	14	gudmap_developingKidney_e15.5_cortic collect duct_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	COL4A5 PNISR CIT JMJD1C NSD3 KIAA1217 TUBE1 SENP7	4.21e-04	281	134	8	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_500	CELF2 KIAA1217 WNK3 NOTCH2	4.94e-04	58	134	4	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_500
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	INTS6L COL4A5 COL4A6 NHSL2 ITGA4 PNISR C4orf54 HPGD KCNJ8 SCAF11 ARHGAP20 MGA TUBE1 SENP7	5.22e-04	797	134	14	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	INTS6L NHSL2 PNISR NSD3 PRDM1 PBRM1 KIAA1217 ANKRD17 SCAF11 ARHGAP20 MGA TUBE1 TOP2A SENP7	5.82e-04	806	134	14	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000	INTS6L LAMB1 ZFAND5 ITGA4 MBNL2 MGA	6.16e-04	164	134	6	gudmap_developingGonad_e11.5_testes and mesonephros_k4_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	INTS6L NHSL2 CHD7 PNISR CIT JMJD1C NSD3 PBRM1 SCAF11 ARHGAP20 MGA TUBE1 TOP2A SENP7	6.49e-04	815	134	14	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200	INTS6L COL4A5 NHSL2 ITGA4 PNISR ARHGAP20	6.56e-04	166	134	6	gudmap_developingGonad_e16.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000	INTS6L OGT UBE4B NHSL2 LAMB1 ZFAND5 ITGA4 MBNL2 SCAF11 ARHGAP20 MGA CAPRIN1 PRRC2A SYMPK	6.81e-04	819	134	14	gudmap_developingGonad_e16.5_testes_1000
ToppCell	facs-Bladder-nan-3m\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A5 COL4A6 LAMB1 SEC31A SEC24D PCDH7 CAPRIN1 DYNC1H1 NOTCH2	2.17e-08	196	149	9	44f5b1b474399c9316729155f2ea95a82ca66e30
ToppCell	facs-Bladder-nan-3m-Epithelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A5 COL4A6 LAMB1 SEC31A SEC24D PCDH7 CAPRIN1 DYNC1H1 NOTCH2	2.17e-08	196	149	9	c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DOCK8 CAST ITGA4 PNISR JMJD1C BPTF CELF2 SCAF11 DYNC1H1	2.58e-08	200	149	9	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	SYNRG BPTF PBRM1 SCAF11 MGA CAPRIN1 DYNC1H1 VPS13B	2.94e-07	193	149	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DAB1 OPHN1 NLGN3 KIAA1217 ARNT2 LRRC7 PCDH7 WNK3	3.72e-07	199	149	8	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	SOBP ZFAND5 CHD7 SEC31A NSD3 BPTF ANXA10 PCDH7	3.72e-07	199	149	8	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	mLN-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	ACER3 DOCK8 ITGA4 INTS8 PICALM BPTF SCAF11 DYNC1H1	3.86e-07	200	149	8	e3c15e0e1c2602b0cc9ab8cc50c978d265350c94
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NHSL2 SOBP LAMB1 ITGA4 ADCY3 KCNJ8 GPC5	2.93e-06	184	149	7	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAMLD1 DAB1 OPHN1 NLGN3 ARNT2 LRRC7 PCDH7	4.92e-06	199	149	7	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	ZFAND5 SEC31A BPTF HPGD SCAF11 DNAH5 PCDH7	4.92e-06	199	149	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAMLD1 DAB1 OPHN1 NLGN3 ARNT2 LRRC7 PCDH7	4.92e-06	199	149	7	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	COL4A5 COL4A6 BPTF YAP1 HEBP1 TOP2A NOTCH2	4.92e-06	199	149	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK---L2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NHSL2 LAMB1 ITGA4 PNISR C4orf54 MBNL2 GPC5	5.08e-06	200	149	7	6ebdae4438bc64c6620416f64a7e22fbca2664bf
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NHSL2 LAMB1 ITGA4 PNISR C4orf54 MBNL2 GPC5	5.08e-06	200	149	7	081ca331b56f85167acfc73af9d2e91f398f8c4d
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NHSL2 LAMB1 ITGA4 PNISR C4orf54 MBNL2 GPC5	5.08e-06	200	149	7	66e2f3e2e9063f17b47621120eb6009405f69e7e
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NHSL2 LAMB1 ITGA4 PNISR C4orf54 MBNL2 GPC5	5.08e-06	200	149	7	940892bea41fde567f138a896d151acccef03a6a
ToppCell	droplet-Marrow-BM-30m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PNISR PICALM PRDM1 YAP1 HPGD HEBP1	2.26e-05	169	149	6	8e7a30eb546fc6fa184ebb76f54b74b278005a84
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK8 ITGA4 JMJD1C TLN1 SCAF11 EP300	3.65e-05	184	149	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A5 COL4A6 SMAP1 PFKP YAP1 PCDH7	4.62e-05	192	149	6	2510f22197502f60fd266b7f42eff040f25b8ae7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A5 COL4A6 SMAP1 PFKP YAP1 PCDH7	4.62e-05	192	149	6	e8e316f396834bcd34843e56e1d86f310fd6aada
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPHN PICALM JMJD1C CELF2 ANKRD17 VPS13B	4.76e-05	193	149	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	GPHN RFX7 OPHN1 YAP1 GPC5 VPS13B	5.18e-05	196	149	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	KDM5A DOCK8 HLA-DPB1 ANKRD17 NOTCH2 C1orf174	5.18e-05	196	149	6	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	SOBP ZFAND5 BPTF HPGD ANXA10 PCDH7	5.64e-05	199	149	6	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMB1 TDG MLLT10 PNISR PRDM10 TLN1	5.64e-05	199	149	6	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW10\|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type.	COL4A5 COL4A6 CHD7 FOXP4 YAP1 TOP2A	5.64e-05	199	149	6	8e72efcd421639ac36ed036ee13f13de070d361f
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial\|6m / Sample Type, Dataset, Time_group, and Cell type.	CAST LAMB1 SEC31A JMJD1C SEC24D PCDH7	5.80e-05	200	149	6	2cc98abf11f5b58707de45a2282f03d47f00f035
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PFKP CELF2 YAP1 AIFM3 GPC5 LGI1	5.80e-05	200	149	6	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PFKP CELF2 YAP1 AIFM3 GPC5 LGI1	5.80e-05	200	149	6	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PFKP CELF2 YAP1 AIFM3 GPC5 LGI1	5.80e-05	200	149	6	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	COL4A5 COL4A6 CHD7 FOXP4 YAP1 TOP2A	5.80e-05	200	149	6	7c495030e6566b81d97b5516d1972e335ce5ed8c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	COL4A6 ZNF772 SIAH3 HIPK3 PPP1R3F ARHGAP20	5.80e-05	200	149	6	a3fcd901cb281920f1bafdfd676399a6dc37355e
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PFKP CELF2 YAP1 AIFM3 GPC5 LGI1	5.80e-05	200	149	6	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAMLD1 DAB1 OPHN1 NLGN3 LRRC7 PCDH7	5.80e-05	200	149	6	ad777683adeb2ce45ade570386235e311fa7ea2d
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	CAST LAMB1 SEC31A JMJD1C SEC24D PCDH7	5.80e-05	200	149	6	0f7431f670f3a175377cefae3479403a881bb8fb
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PFKP CELF2 YAP1 AIFM3 GPC5 LGI1	5.80e-05	200	149	6	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	LAMB1 JMJD1C BPTF TLN2 SCAF11 PCDH7	5.80e-05	200	149	6	7c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PFKP CELF2 YAP1 AIFM3 GPC5 LGI1	5.80e-05	200	149	6	01819446deeab9054f5cfe889d53bb49d137dbc0
Computational	Genes upregulated in subsets of cells of a given type within various tumors	OGT LAMB1 PNISR BPTF DYNC1H1	4.92e-05	50	87	5	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	2.10e-14	46	145	10	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L4 USP17L2 USP17L1 USP17L10 CHD7 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13	3.92e-14	69	145	11	DOID:1682 (implicated_via_orthology)
Disease	Leiomyomatosis, esophageal and vulval, with nephropathy	COL4A5 COL4A6	2.40e-05	2	145	2	C1839884
Disease	Leiomyoma, Epithelioid	COL4A5 COL4A6	2.40e-05	2	145	2	C0086533
Disease	Malignant neoplasm of breast	KIF6 DDX59 HLCS LEPR FOXP4 PBRM1 CDH20 YAP1 MIF NFYC LRRC7 PRRC2A EP300 TOP2A VPS13B NOTCH2	8.09e-05	1074	145	16	C0006142
Disease	Cannabis use, age at onset	CAST CDH20 LRRC7	1.06e-04	19	145	3	EFO_0004847, EFO_0007585
Disease	Diffuse Large B-Cell Lymphoma	SEC31A PRDM1 EP300 NOTCH2	1.57e-04	55	145	4	C0079744
Disease	response to perphenazine	MYT1L C4orf54 LGI1	2.78e-04	26	145	3	GO_0097334
Disease	Autistic Disorder	DAB1 LAMB1 ITGA4 JMJD1C NLGN3 NLGN4X MIF	3.20e-04	261	145	7	C0004352
Disease	Drug-Induced Stevens Johnson Syndrome	CELF2 MIF EP300	3.87e-04	29	145	3	C1274933
Disease	Mycoplasma-Induced Stevens-Johnson Syndrome	CELF2 MIF EP300	3.87e-04	29	145	3	C3658301
Disease	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	CELF2 MIF EP300	3.87e-04	29	145	3	C3658302
Disease	Toxic Epidermal Necrolysis	CELF2 MIF EP300	3.87e-04	29	145	3	C0014518
Disease	risk-taking behaviour	MYT1L ACTR10 UBQLN4 DAB1 OMG BPTF PBRM1 PCDH7 CDH8 EP300 SENP7 IPO11	4.08e-04	764	145	12	EFO_0008579
Disease	Stevens-Johnson Syndrome	CELF2 MIF EP300	4.28e-04	30	145	3	C0038325
Disease	immature granulocyte measurement	CHD7 ITGA4	4.96e-04	7	145	2	EFO_0803543
Disease	Obesity, Morbid	ADCY3 LEPR	4.96e-04	7	145	2	C0028756
Disease	coloboma (implicated_via_orthology)	LAMB1 YAP1	6.59e-04	8	145	2	DOID:12270 (implicated_via_orthology)
Disease	Autism Spectrum Disorders	MYT1L NLGN3 NLGN4X USH2A	8.32e-04	85	145	4	C1510586
Disease	gait measurement	GPHN HLA-DPB1 MLLT10 JMJD1C C19orf12	8.94e-04	150	145	5	EFO_0007680
Disease	autism spectrum disorder (implicated_via_orthology)	KDM5A SCAMP1 CHD7 NLGN3 NLGN4X	9.48e-04	152	145	5	DOID:0060041 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of breast	PBRM1 EP300 NOTCH2	1.08e-03	41	145	3	C0496956
Disease	Breast adenocarcinoma	PBRM1 EP300 NOTCH2	1.08e-03	41	145	3	C0858252
Disease	autistic disorder (is_implicated_in)	LAMB1 NLGN3 NLGN4X	1.16e-03	42	145	3	DOID:12849 (is_implicated_in)
Disease	Neurodevelopmental Disorders	MYT1L DOCK8 DHX30 KCNQ2	1.16e-03	93	145	4	C1535926
Disease	stromal cell-derived factor 1 alpha measurement	DAB1 CDH20 ACSF3	1.24e-03	43	145	3	EFO_0008293
Disease	Adenoid Cystic Carcinoma	JMJD1C MGA EP300 TOP2A	1.52e-03	100	145	4	C0010606
Disease	collagen disease (implicated_via_orthology)	COL4A5 COL4A6	1.53e-03	12	145	2	DOID:854 (implicated_via_orthology)
Disease	Neuroblastoma	DOCK8 YAP1 TOP2A	1.61e-03	47	145	3	C0027819
Disease	anti-basement membrane glomerulonephritis (implicated_via_orthology)	ITGA4 MIF	2.10e-03	14	145	2	DOID:4780 (implicated_via_orthology)
Disease	granulocyte percentage of myeloid white cells	DOCK8 CHD7 ITGA4 JMJD1C LEPR USF1	2.16e-03	268	145	6	EFO_0007997
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	CAST MLLT10 ADCY3 BPTF C19orf12 PRRC2A SENP7	2.22e-03	364	145	7	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	free androgen index	UBE4B CHD7 JMJD1C LEPR CLYBL UGT2A1 DNMBP	2.58e-03	374	145	7	EFO_0007005
Disease	serum albumin measurement	MAMLD1 MLLT10 DCST1 JMJD1C LEPR PRDM1 ARNT PCDH7 CDHR4	2.70e-03	592	145	9	EFO_0004535
Disease	syndromic intellectual disability (implicated_via_orthology)	KDM5A OPHN1	2.75e-03	16	145	2	DOID:0050888 (implicated_via_orthology)
Disease	T-Cell Lymphoma	MGA EP300	2.75e-03	16	145	2	C0079772
Disease	diabetic retinopathy (implicated_via_orthology)	ITGA4 EP300	2.75e-03	16	145	2	DOID:8947 (implicated_via_orthology)
Disease	alcohol use disorder (implicated_via_orthology)	KDM5A JMJD1C PBRM1 EP300 NOTCH2	2.83e-03	195	145	5	DOID:1574 (implicated_via_orthology)
Disease	Astrocytosis	ITGA4 LEPR	3.11e-03	17	145	2	C3887640
Disease	pre-eclampsia (biomarker_via_orthology)	ITGA4 LEPR	3.11e-03	17	145	2	DOID:10591 (biomarker_via_orthology)
Disease	Acute myeloid leukemia	MLLT10 PICALM	3.11e-03	17	145	2	cv:C0023467
Disease	Gliosis	ITGA4 LEPR	3.11e-03	17	145	2	C0017639
Disease	LEUKEMIA, ACUTE MYELOID	MLLT10 PICALM	3.11e-03	17	145	2	601626
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	ARNT EP300 NOTCH2	3.40e-03	61	145	3	C1961102
Disease	disease free survival	CCDC168 CDH8	3.48e-03	18	145	2	EFO_0000409
Disease	Obesity	MYT1L ADCY3 LEPR EP300 VPS13B	3.50e-03	205	145	5	C0028754
Disease	Prostatic Neoplasms	ZFAND5 CHD7 DHX30 FOXP4 CELF2 HPGD MIF MGA TOP2A	3.50e-03	616	145	9	C0033578
Disease	Malignant neoplasm of prostate	ZFAND5 CHD7 DHX30 FOXP4 CELF2 HPGD MIF MGA TOP2A	3.50e-03	616	145	9	C0376358
Disease	neutrophil count, eosinophil count	DOCK8 CHD7 ITGA4 JMJD1C LEPR	4.12e-03	213	145	5	EFO_0004833, EFO_0004842
Disease	testosterone measurement	NHSL2 UBQLN4 CAST CHD7 JMJD1C LEPR OPHN1 ARNT CLYBL YAP1 UGT2A1 ANXA10 DNMBP USH2A	4.16e-03	1275	145	14	EFO_0004908
Disease	alpha-tocopherol measurement	GPC5 USH2A	4.30e-03	20	145	2	EFO_0007898

Protein segments in the cluster

Peptide	Gene	Start	Entry
PFQQLMAEAPNMAVV	TDG	21	Q13569
QQPGQPEVFQEMLSM	ARNT	751	P27540
PQFTNSPTMVIMVGL	PFKFB1	36	P16118
LDAGFQMPTPIQMQA	DDX52	181	Q9Y2R4
QMMPRITPQSGLNQF	EP300	701	Q09472
GLNQFGQMSMAQPPI	EP300	711	Q09472
NTVSNLIMIIPPMFG	ACER3	36	Q9NUN7
PQEFGDQDILQMFMP	CELF2	431	O95319
IPMMPVSQTQIPQYI	COL4A6	1551	Q14031
MTSGQFKPVPQILME	C19orf12	76	Q9NSK7
IFPAPNFNPIMDAQM	ANXA10	11	Q9UJ72
LGPPVNVPQVSSMQM	AP2B1	636	P63010
RGFIPVNKMMQTNVP	AIFM3	446	Q96NN9
LPNGPILQNSMVTVM	CDKL4	341	Q5MAI5
TFQILVMLEMTPQQG	HLA-DPB1	181	P04440
MVPMQQAQVPNIDFE	DNMBP	811	Q6XZF7
GATCVMMPEFSPQQV	ACSF3	261	Q4G176
AQMGFAPIQPLAMPQ	ANKRD17	946	O75179
SNIPMMDQKAIFQQP	DHX30	706	Q7L2E3
TPVMVQPGAPQQVMT	BPTF	2206	Q12830
MQTVFNMNAPVPPVN	CAPRIN1	516	Q14444
PMGQQMPIDQGFASL	CHD7	36	Q9P2D1
GQPQMTTEVPVLVMV	CDHR4	421	A6H8M9
PFMTQQQMSPLSREG	CIT	36	O14578
NNPPLEMMFDVGKTQ	ACTR10	391	Q9NZ32
QQPGQTEVFQDMLPM	ARNT2	676	Q9HBZ2
EQPMNLIPFVETAMG	CLYBL	161	Q8N0X4
GVAILNTSVAPMMNP	OR6C1	271	Q96RD1
LINMTGDLMPPNQVD	INTS6L	701	Q5JSJ4
GAMPNTLQITPAMAQ	INTS6L	761	Q5JSJ4
PGPPQLSVMNQMQQE	INTS8	166	Q75QN2
ENLMTPSNMGVIFGP	OPHN1	516	O60890
GEQPTQTVMPGQVMR	GPHN	396	Q9NQX3
PDMPVFTEQMQIQQE	NCLN	436	Q969V3
VAFPTAMMPQQDGQV	NOTCH2	2351	Q04721
TPMGMLNQQLTPVAG	PBRM1	1471	Q86U86
NNSSLMVPKVQFMTP	KCNJ8	401	Q15842
MVPKVQFMTPEGNQN	KCNJ8	406	Q15842
LQPVMFRNPGSVMGI	MGA	1826	Q8IWI9
PMEQMFSFSQPSVNE	LRRC7	1081	Q96NW7
PLFEMPQGSFINMST	LRIT2	66	A6NDA9
VSPFGNIPQRVMGQM	GPC5	201	P78333
PVLLEMMQTLQGPTN	IPO11	426	Q9UI26
QVLEPQNVDPSMVQM	JMJD1C	226	Q15652
MFQTPQEMGLIVIAA	HLCS	486	P50747
TMGNLPEPDQNLVAM	CARF	631	Q8N187
SGYEVPTPIQMQMIP	DDX59	221	Q5T1V6
MSGNILVGPEIQVMQ	DSG4	991	Q86SJ6
PGSPEVTMNISQMIT	LIPF	26	P07098
VNIYMQRMGIPPTET	KCNQ2	641	O43526
NLQPNSPVGMVTVMD	PCDH7	651	O60245
PMVMVPATVSNNVPG	PFKP	531	Q01813
GISENMAVPLMPDQQ	KIF6	621	Q6ZMV9
MEMPSTPQQLQNLTE	LAMB1	1531	P07942
IFQSPLMSVQPINMV	LEPR	221	P48357
QMLTPQQMQQILSPP	FOXP4	111	Q8IVH2
MPMFIVNTNVPRASV	MIF	1	P14174
SSEIQMMTLPPGQFV	PRDM10	1046	Q9NQV6
PFMTLPMDTTISINN	OR4D6	261	Q8NGJ1
PAMLQTNMGNPVTVV	HIPK3	151	Q9H422
LFQSGVSLMGVQMPN	KDM5A	171	P29375
QVTMPAGQDLAQPMF	NFYC	426	Q13952
IGAVLFTVVTPMMNP	OR1S2	286	Q8NGQ3
MTPNTITMIPNSLVG	NLGN3	806	Q9NZ94
VSRPQQFDVMVMPNL	IDH3G	261	P51553
NPFIALMIQPIVTMT	C2orf83	11	Q53S99
AMQMTPFPTQVEELL	DOCK8	1586	Q8NF50
QQQMVMGAQPPVAQV	DAB1	351	O75553
VMESNNMPCLPQPVG	DCST1	531	Q5T197
AMEMNNPSQVGSVPV	CDH20	466	Q9HBT6
IAAMMQIQNIFVVPP	DHX35	511	Q9H5Z1
PMSMQPLKGQSIQPF	COL4A5	1546	P29400
MVGMPFPNIRSAELQ	DDX11L8	796	A8MPP1
DLPMVALEQMQGFNP	ADCY3	811	O60266
GPNVMIMQPTQAVQE	DUXB	231	A0A1W2PPF3
PVMRLSMPTQQASGQ	ELF2	506	Q15723
MNPTETKAIPVSQQM	CAST	1	P20810
MNGNIMGSPFVVPQT	MAMLD1	136	Q13495
MLAQQMQFMFPGTPL	MBNL2	96	Q5VZF2
NSMAPNVSVEIMVPN	ITGA4	816	P13612
PMLQIQRDAATIMQP	DYNC1H1	2411	Q14204
QQEMTIFSGPQLMPV	KLF17	121	Q5JT82
PMNQSQVLMSGSPLE	CDH8	31	P55286
PKMLPQLEQSFMVNT	CCDC168	621	Q8NDH2
QPMPVSRFFGNVELM	C1orf174	191	Q8IYL3
VPMTSQQQAVAPMSI	C4orf54	1646	D6RIA3
QQVDGSQLPINMMQP	SCAF11	1196	Q99590
PNTITMIPNTLTGMQ	NLGN4X	776	Q8N0W4
VTMNPEFGLFLTMNP	DNAH5	2071	Q8TE73
QKMGPFQPMNIFLRQ	DNAH5	4381	Q8TE73
NTVPQGSFLQLSMMP	KRBA2	71	Q6ZNG9
ALNMPVIPMNTIAEA	OGT	771	O15294
VVQILMNLVGPMLNP	OR10D3	271	Q8NH80
MSSLAGLMPVAQQPV	HPGD	136	P15428
MEAMSPQQETLGGQP	ARHGAP20	1	Q9P2F6
MLSEQSPQQSIPMAF	USH2A	1401	O75445
NPVMENISSIMPSNE	SENP7	501	Q9BQF6
MAAVAMTPNPVQTLQ	TRIM41	1	Q8WV44
GLMPMQQQGFPMVSV	SYNRG	41	Q9UMZ2
QKTNPNQPIMPMVTQ	NHSL2	811	Q5HYW2
NQPIMPMVTQSDLRS	NHSL2	816	Q5HYW2
MGNFGLIMLIQISPQ	OR5AL1	56	P0C617
AQQMLLPMVDSQLPV	PRRC2A	1976	P48634
IIQPSPSLLGMNQMD	SATL1	261	Q86VE3
TLQMSQAPQSPQIPM	KIAA1217	926	Q5T5P2
PQIPMNGSAMQSLFI	KIAA1217	936	Q5T5P2
PQFFATMMLIGTPTQ	SIAH3	181	Q8IW03
LTGLNQNIPVGIMMI	SCAMP1	251	O15126
PYPGELTMMNLTQTQ	PRDM1	211	O75626
LMNSNAMEIFIQPTP	SI	296	P14410
MPNNFSEMPQQSTTL	OMG	386	P23515
ALSGQQQGPPVAEMM	EARS2	491	Q5JPH6
PQMMVVTDVGEVFVP	SEC24D	506	O94855
NVVIFGVPQMMLQLE	ATPSCKMT	156	Q6P4H8
LNGVMQTPVTMSQNP	MLLT10	916	P55197
PDTYMNSRPVIINMN	C12orf29	276	Q8N999
QMGSVPVMTQPTLIY	PICALM	616	Q13492
LDMQPYMSQQNTGPL	USP17L3	301	A6NCW0
PVAALPVTQQMTEMS	ZFAND5	91	O76080
LDMQPYMSQQNTGPL	USP17L4	301	A6NCW7
IFMPANTTSILQPMD	TIGD1	321	Q96MW7
MDLNEISMNLVPFPQ	TUBE1	281	Q9UJT0
GPVPLPIFMEQQIMQ	SOBP	391	A7XYQ1
GSMPPAQQQITSGQM	TLN1	466	Q9Y490
LMAVINGCQMSVPPN	PSTK	91	Q8IV42
EVMFMTNPAVQPRTQ	UBE4B	936	O95155
NVTAPTSPPVQQNMM	YAP1	211	P46937
LDMQPYMSQQNTGPL	USP17L13	301	C9JLJ4
FMGNAQTGVMPLPQN	SMAP1	376	Q8IYB5
PVMPQNMIPLEDSNS	TEX13C	551	A0A0J9YWL9
PQMTLQVSDVPMTGN	PPP1R3F	376	Q6ZSY5
SQSVPLTVMMQTAFP	RFX7	1126	Q2KHR2
LDMQPYMSQQNTGPL	USP17L1	301	Q7RTZ2
PAVVVPYMMVLQENG	SLC9B1	226	Q4ZJI4
SFMQGIMGNTIQQPP	NSD3	6	Q9BZ95
LAVVMQQLMEQSPLP	SYMPK	981	Q92797
NMIESQMGPSQTEPV	ZBTB24	621	O43167
MEVSPLQPVNENMQV	TOP2A	1	P11388
QAQPETKPEGTAMQM	TSSK1B	321	Q9BXA7
MQQQPVVAVPLVMPV	VPS13B	976	Q7Z7G8
FNVGSMPSPQQQVMV	TLN2	466	Q9Y4G6
LDMQPYMSQQNTGPL	USP17L8	301	P0C7I0
EASGQQSMVEQPPGM	PNISR	46	Q8TF01
LDMQPYMSQQNTGPL	USP17L6P	301	Q6QN14
GQMLAVMEQPSGSPV	WDSUB1	86	Q8N9V3
PRSMTDPQNMEFQVP	TCTN3	286	Q6NUS6
TSPIMNPLGDPQSQM	SEC31A	1021	O94979
LDMQPYMSQQNTGPL	USP17L22	301	D6RA61
SNPEMLSQIMENPLV	UBQLN4	191	Q9NRR5
AQMMVNVPLFAGNPQ	UBQLN4	421	Q9NRR5
LDMQPYMSQQNTGPL	USP17L17	301	D6RBQ6
VPMVGVPMFADQPDN	UGT2A1	386	P0DTE4
PMGPAQVPMNSEVIV	ZNF772	6	Q68DY9
LDMQPYMSQQNTGPL	USP17L2	301	Q6R6M4
LDMQPYMSQQNTGPL	USP17L10	301	C9JJH3
FVMMSPQEVLQGGSQ	USF1	161	P22415
QPGMNMQAFPTSSVQ	WNK3	1776	Q9BYP7
MGMTVPISFAVFPNE	HEBP1	76	Q9NRV9
MPSRGSMVFQPLQIN	LGI1	471	O95970
TPLEPMSPQQQAVMN	MYT1L	791	Q9UL68